Quantcast

Latest Beta amyloid Stories

2014-09-16 08:29:21

INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. The progression of Alzheimer's disease is characterized by the accumulation of amyloid plaque in the brain. BACE is an enzyme associated with the development of beta-amyloid. Inhibiting BACE...

2014-08-18 08:29:41

Neurotrope's Collaborator BRNI, Publishes Article in the Journal of Alzheimer's Disease describing correlation of PKCe levels and degree of disease PLANTATION, Fla., Aug. 18, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) today announced that results from a new study, entitled, "PKCe Deficits in Alzheimer's Disease Brains and Skin Fibroblasts," published in the recent edition of the peer-reviewed Journal of Alzheimer's Disease and co-authored by Tapan K. Khan, Ph.D.; Abhik Sen,...

2014-07-29 23:02:07

A team of scientists, led by Western University of Health Sciences Professor Doug Ethell, PhD, has developed a blood test for Alzheimer’s disease risk that may lead to earlier detection and the development of Alzheimer’s disease interventions, according to an article published July 29, 2014. Pomona, California (PRWEB) July 29, 2014 A team of scientists, led by Western University of Health Sciences Professor Doug Ethell, PhD, has developed a blood test for Alzheimer’s disease risk...

2014-07-17 16:26:33

MELBOURNE, Australia, July 17, 2014 /PRNewswire/ -- Prana Biotechnology (NASDAQ: PRAN; ASX: PBT) has today provided an update on its clinical development program for Alzheimer's disease. Professor Colin Masters, the Florey Institute of Neuroscience and Mental Health, The University of Melbourne, will today include data from Prana's Phase 2 IMAGINE and EURO trials in his presentation at the Alzheimer's Association International Conference in Copenhagen, Denmark. The presentation is...

Research Identifies Potential Cause Of Preeclampsia
2014-07-17 03:41:34

Nationwide Children's Hospital New research has identified a potential cause of and a better diagnostic method for preeclampsia, one of the most deadly and poorly understood pregnancy-related conditions in the world. The international team, led by researchers at Nationwide Children's Hospital, discovered that the disease may result from a collection of protein mishaps like those associated with Alzheimer's disease. Their findings, released today by Science Translational Medicine, have...

2014-07-16 08:28:20

Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data showing that beta-amyloid imaging was associated with altered diagnosis and management of patients with Alzheimer's disease. Change in management was observed in both patients who met and did not meet the Appropriate Use Criteria (AUC), which were developed by the Society of Nuclear Medicine and Molecular...

2014-07-16 04:21:29

ATTN: Please refer to www.alz.org/aaic/press.asp or call (312) 335-4078 for individual stories included here that were presented before Wednesday, July 16, and have come off embargo. COPENHAGEN, Denmark, July 16, 2014 /PRNewswire-USNewswire/ -- New studies reported at the Alzheimer's Association International Conference 2014 (AAIC® 2014) in Copenhagen cover the spectrum of Alzheimer's disease and dementia research. Data includes advances in early detection and diagnosis, identifying...

2014-07-16 04:21:24

- New Brain Protein Connected for First Time to Cognitive Decline and Alzheimer's Disease. COPENHAGEN, Denmark, July 16, 2014 /PRNewswire-USNewswire/ -- Results from four research studies reported as "developing topics" at the Alzheimer's Association International Conference(®) 2014 (AAIC(®) 2014) in Copenhagen include significant advances in evidence regarding treatment and early detection of Alzheimer's disease and dementia, as well as new ideas in the basic brain science of dementia that...

2014-07-14 12:20:58

Cedars-Sinai Medical Center Preliminary results show the device, created at Cedars-Sinai and developed by NeuroVision Imaging, may provide highly predictive early detection of changes associated with Alzheimer's disease A noninvasive optical imaging device developed at Cedars-Sinai can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease, according to preliminary results from investigators conducting a clinical trial in...

Research Opens Doors To Novel Alzheimer's Diagnosis Methods
2014-07-14 12:28:32

Brett Smith for redOrbit.com - Your Universe Online The confirmation of an Alzheimer’s diagnosis typically involves one of two procedures – a spinal tap or a brain-imaging scan. However, new research has opened the door to other possible methods – including a blood test, sense of smell exam or determining protein build-up in the eyes. Based in tests conducted on hundreds of patients, reports on the research are to be presented at the Alzheimer's Association International...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related